Trial Profile
A Phase I, Open Label, Randomized, Single-Dose Crossover Study To Compare the Pharmacokinetics of Two NP101 Patch (Sumatriptan Iontophoretic Transdermal System) Applications with and without Controlled Heat
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2012
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- 31 Jul 2012 New trial record
- 24 Jun 2012 Results presented at the 54th Annual Scientific Meeting of the American Headache Society.